The Venture Codex Logo

The Venture Codex

Fourier Intelligence

No. 2388, Xiupu Road Floor 2, Building 12, Shanghai, Pudong, 201203, China

Overview

Fourier Intelligence develops intelligent rehabilitation robotics and AI/haptic solutions, centered on its product-level platform RehabHub™, which is used in neurorehabilitation, elderly care, and community-based rehabilitation settings. RehabHub™ comprises compact, modular, interconnected robots designed to deliver functional training and assist clinicians in clinical rehabilitation environments. The company has installations in more than 1,000 institutions and serves customers across 50 countries. Fourier has established multiple R&D centres in Singapore, Chicago, Phoenix, Zürich, Melbourne, Madrid, Kobe, and Kuala Lumpur. Leadership includes Founder and Group CEO Alex Gu and Co-Founder and Group Deputy CEO Zen Koh. The company intends to use newly raised funds to invest in core technology development, talent acquisition, and global market expansion. Fourier Intelligence develops rehabilitation robotic systems and comprehensive intelligent rehabilitation solutions, including its fully integrated Fourier Intelligence RehabHubTM Concept. The company completed an RMB 100M Series C financing to support product-line expansion and enhancement of its RehabHub concept. Leadership includes Founder, Group CEO and Executive Chairman Alex Gu, and Co-Founder, Group Deputy CEO and Chief Strategy Officer Zen Koh. Fourier Intelligence operates from Shanghai and maintains offices in Singapore, Malaysia, Guangzhou and Zhuhai. The company positions itself as a global provider of rehabilitation robotics, focused on R&D, manufacturing and marketing of its systems. Founded in 2015 by Alex Gu, Fourier Intelligence designs and develops mass-market rehabilitation robotics. The company has pursued collaborations through Memorandums of Understanding with institutions including Shirley Ryan AbilityLab, the University of Melbourne and ETH Zurich to establish joint labs. In July 2019 it announced a Series B round, and more recently completed a Series B+ financing. Proceeds from the Series B and B+ rounds are estimated at close to RMB 100 million (US$14.11m). Fourier plans to use the funds to spur R&D, facilitate marketing efforts and formulate an intelligent rehabilitation ecosystem. The company is based in Shanghai, China.

Total raised
$15M
Funding rounds
3
Latest round
Series C
Latest activity
Oct 2020

Industries

  • Medical
  • Medical Device
  • Rehabilitation
Visit website

Recent funding

  1. Series C

    Oct 2020

    $15M

Team